Author

Zhong Dong

Observed names: Dong, Zhong, Zhong Yi Dong, Zhong yi Dong

Institution: Huizhou Central People's Hospital

Observed institutions: Nanfang Hospital, Huizhou Central People's Hospital, Beijing Center for Disease Prevention and Control, Southern Medical University

ORCID: 0009-0007-4203-6502

Observed ORCID: 0009-0007-4203-6502

OpenAlex ID: A5108686805

Nuclear translocation of ISG15 regulated by PPP2R2B inhibits cisplatin resistance of bladder cancer

2024 · Gaowei Huang, Jinwen Liu, et al. · Cellular and Molecular Life Sciences · 12

Multi-omics profiling highlights karyopherin subunit alpha 2 as a promising biomarker for prognosis and immunotherapy respond in pediatric and adult adrenocortical carcinoma

2024 · Yihao Chen, Shumin Fang, et al. · Annals of Medicine · 6

Lamin B1: a novel biomarker in adult and pediatric adrenocortical carcinoma

2024 · Yihao Chen, Jiahong Chen, et al. · Endocrine Related Cancer · 3

[Investigation of nutrition and feeding status among children under 2 years in Beijing].

2006 · Yao Zhao, Lei Huang, et al. · PubMed · 3

Abstract 4065: Prognostic and predictive role of tumor mutation burden and copy number alterations across metastatic cancer: Immunotherapeutic implications

2019 · Xin-Ran Tang, Zhong Yi Dong, et al. · Cancer Research · 1

Cell division cycle 20 promotes tumor progression and predicts poor clinical outcome in childhood and adult adrenocortical carcinoma

2025 · Jiahong Chen, Peisheng Huang, et al. · Journal of Clinical & Translational Endocrinology

Abstract 4065: Prognostic and predictive role of tumor mutation burden and copy number alterations across metastatic cancer: Immunotherapeutic implications

2019 · Xin-Ran Tang, Zhong Yi Dong, et al. · Immunology

Combination of biomarker and clinicopathologic characters to circle out beneficiaries through second-line immunotherapy: A meta analyse.

2017 · C Zhang, Wenzhao Zhong, et al. · Journal of Clinical Oncology

Works count: 9

Citation count: 25

H-index: 3

I10-index: 1